Sorbus Advisors LLC

About
Services
Professionals
Resources
Blog
Contact

BioPharmaceutical Valuations in Purchase Accounting

November 20, 2015 | by Max Fonarev

Recent Posts

Covid-19 | Valuation Update | Three Months In
COVID-19 | Valuation Update
Valuing VC Investments – An Intuitive Example
Valuation Market Multiples: Not So Simple
Purchase Price Allocation (ASC 805) Benchmarking Study IT 2018

Labels

Fair Market Value Portfolio Valuation ASC 805 Financial Reporting Purchase Price Allocation Tax Compliance ASC 805 Purchase Accounting Fair Value Tax Valuation Transactions Business Interests Term Sheet Intangible Asset Valuation Life Sciences Purchase Accounting 409A Valuation IP Valuation Financial Instruments

Twitter
Linkedin

© 2021 Sorbus Advisors LLC. All Rights Reserved. | Terms of Use | Privacy Policy

Please leave your email address below to view this publication. By doing so, you consent to receive our quarterly newsletters. You can unsubscribe at any time.

First Name*
Last Name*
Company
Newsletter Sign up*